As part of one of the
nation’s leading academic medical centers, UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center offers a broad spectrum of clinical
trials aimed at improving the outcomes of patients with leukemia. Patients
should talk to their doctor about joining a clinical trial.
Some of our current
clinical trials are:
- Beat AML
- A Multiple Dose, Dose Escalation
Trial of AEB1102 in Patients with AML or MDS
- Combination Chemotherapy in Treating
Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic
Leukemia and Ph-Like TKI Sensitive Mutations
- Collecting and Storing Samples of
Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic
Leukemia or Non-Hodgkin Lymphoma
See all current clinical trials.
Groundbreaking Initiative to Beat Aggressive Form of
Leukemia
Only 27 percent of
patients with acute myeloid leukemia live at least five years after the cancer
is found. UT Southwestern is trying to change that. We have been selected
as the only site in Texas for a national Cancer Moonshot clinical trial to find individually tailored approaches
to better treat acute myeloid leukemia. This trial is known as the Beat AML trial.
